Overview

A Study to Access the Efficacy and Safety of Meloxicam in Patients With Osteoarthritis of the Knee

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To Access the Efficacy and Safety of Meloxicam 7.5mg once daily over a treatment period of 56 days
Phase:
Phase 4
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Meloxicam